Literature DB >> 34193467

Hypermobile Ehlers-Danlos syndrome (hEDS) phenotype in fragile X premutation carriers: case series.

Nattaporn Tassanakijpanich1,2, Forrest J McKenzie2,3, Yingratana A McLennan2,4, Elisabeth Makhoul2,5, Flora Tassone2,5, Mittal J Jasoliya5, Christopher Romney2, Ignacio Cortina Petrasic2,3, Kaye Napalinga2,6, Caroline B Buchanan7, Paul Hagerman2,5, Randi Hagerman8,4, Emily L Casanova9.   

Abstract

BACKGROUND: While an association between full mutation CGG-repeat expansions of the Fragile X Mental Retardation 1 (FMR1) gene and connective tissue problems are clearly described, problems in fragile X premutation carriers (fXPCs) CGG-repeat range (55-200 repeats) of the FMR1 gene may be overlooked.
OBJECTIVE: To report five FMR1 fXPCs cases with the hypermobile Ehlers-Danlos syndrome (hEDS) phenotype.
METHODS: We collected medical histories and FMR1 molecular measures from five cases who presented with joint hypermobility and loose connective tissue and met inclusion criteria for hEDS.
RESULTS: Five cases were female and ranged between 16 and 49 years. The range of CGG-repeat allele sizes ranged from 66 to 150 repeats. All had symptoms of hEDS since early childhood. Commonalities in molecular pathogenesis and coexisting conditions between the fXPCs and hEDS are also presented. The premutation can lead to a reduction of fragile X mental retardation protein, which is crucial in maintaining functions of the extracellular matrix-related proteins, particularly matrix metallopeptidase 9 and elastin. Moreover, elevated FMR1 messenger RNA causes sequestration of proteins, which results in RNA toxicity.
CONCLUSION: Both hEDS phenotype and premutation involvement may co-occur because of related commonalities in pathogenesis. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  gene expression; genetic predisposition to disease; genetics; human genetics; medical

Mesh:

Substances:

Year:  2021        PMID: 34193467      PMCID: PMC8717836          DOI: 10.1136/jmedgenet-2020-107609

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   5.941


  4 in total

Review 1.  Fragile X Premutation: Medications, Therapy and Lifestyle Advice.

Authors:  Deepika Kour Sodhi; Randi Hagerman
Journal:  Pharmgenomics Pers Med       Date:  2021-12-29

2.  The Relationship Between Generalised Joint Hypermobility and Autism Spectrum Disorder in Adults: A Large, Cross-Sectional, Case Control Comparison.

Authors:  Martin R Glans; Nils Thelin; Mats B Humble; Marie Elwin; Susanne Bejerot
Journal:  Front Psychiatry       Date:  2022-02-08       Impact factor: 4.157

3.  Increased Pain Symptomatology Among Females vs. Males With Fragile X-Associated Tremor/Ataxia Syndrome.

Authors:  Devon Johnson; Ellery Santos; Kyoungmi Kim; Matthew D Ponzini; Yingratana A McLennan; Andrea Schneider; Flora Tassone; Randi J Hagerman
Journal:  Front Psychiatry       Date:  2022-01-20       Impact factor: 4.157

4.  Connective Tissue Disorders and Fragile X Molecular Status in Females: A Case Series and Review.

Authors:  Merlin G Butler; Waheeda A Hossain; Jacob Steinle; Harry Gao; Eleina Cox; Yuxin Niu; May Quach; Olivia J Veatch
Journal:  Int J Mol Sci       Date:  2022-08-13       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.